Web Meeting Info
Join Zoom Meeting https://hl7-org.zoom.us/j/8033561462
Meeting ID: 803 356 1462
Chair: Russell Leftwich or Laura Heermann-Langford or James McClay or James Tcheng or Bruce Bray
Scribe:
Attendance
Name | Affiliation | Name | Affiliation | Name | Affiliation | Name | Affiliation | Name | Affiliation | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
X | Russell Leftwich | InterSystems | X | Saul Kravitz | Mitre | |||||||||
x | Laura H Langford | Graphite Health | X | Kurt Allen | ||||||||||
X | Jim McClay | U Missouri | X | Chris Melo | Phillips | |||||||||
X | Jimmy Tcheng | Duke Univ | X | Maria Michaels | ||||||||||
Bruce Bray | Univ Utah | X | Mark Kramer | Mitre | ||||||||||
Quorum (Chair +3) met?
HL7 Antitrust Policy
Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM)
Agenda
- Antitrust Statement
- Review Agenda
- Approve previous meeting minutes 2023-02-09 CIC Meeting Notes
- Motion made by Russ L./ seconded by Kurt Allen
- Project Proposals/PSS Reviews
- mCODE Block Vote
- May WGM Agenda
- Project Updates
Minutes
mCODE Block Vote
items reviewed. Motion made to approve Jim McClay, 2nd by Saul, 8 = approve, 0 = oppose, 0 abstain,
Next steps for mCode - all ballot comments have been resolved. Ready to re-ballot in May. Final Content Deadline = March 26th. mCODE will meet on March 23rd. March 9th will be announced to review the final ballot version.
May WGM agenda reviwed and confirmed .
Review of open project proposals:
- PSS-2155Getting issue details... STATUS
comment left: CIC has reviewed and is interested in the project from the clinician/clinical perspective. There are questions in our group of perhaps a need for two different resources and not just profiles of the current resource to fully meet the needs of research and clinical care. We are willing to be co-sponsors or at the very least an interested party.
- PSS-2153Getting issue details... STATUS
comment: CIC finds this project intriguing, but would like to know more by what is meant by "a patient-centric view of FHIR". More information on the scope and work intended to be done would be helpful.
- PSS-2149Getting issue details... STATUS
CIC has reviewed. The project looks laudable, but beyond the scope or bandwidth of CIC at this time. We will watch the project as it evolves with interest.